New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers

Tamara Grigg

Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of

Advocating for upper GI cancers: oesophageal and gastric cancer update

Tamara Grigg

An important part of Pancare supporting patients with upper gastrointestinal (GI) cancers is advocating for better treatment and unmet needs.